CF

Cantor Fitzgerald Portfolio holdings

AUM $3.36B
1-Year Est. Return 29.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+29.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.36B
AUM Growth
-$1.74B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
389
New
Increased
Reduced
Closed

Top Buys

1 +$172M
2 +$97.5M
3 +$88.4M
4
MBAV
M3-Brigade Acquisition V Corp
MBAV
+$81M
5
CRCL
Circle Internet Group
CRCL
+$64.8M

Top Sells

1 +$363M
2 +$309M
3 +$109M
4
TSLA icon
Tesla
TSLA
+$95.6M
5
NVDA icon
NVIDIA
NVDA
+$91.7M

Sector Composition

1 Technology 49.92%
2 Financials 17.84%
3 Consumer Discretionary 6.2%
4 Communication Services 5.99%
5 Healthcare 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
301
Teva Pharmaceuticals
TEVA
$37.5B
-68,890
TGB
302
Taseko Mines
TGB
$2.8B
-122,500
TGTX icon
303
TG Therapeutics
TGTX
$5.67B
-32,000
THRD
304
DELISTED
Third Harmonic Bio
THRD
-86,325
TLT icon
305
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
-15,911
TMC icon
306
TMC The Metals Company
TMC
$2.33B
-50,000
TMF icon
307
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.82B
-32,195
TMUS icon
308
T-Mobile US
TMUS
$219B
-17,347
TQQQ icon
309
ProShares UltraPro QQQ
TQQQ
$30.9B
-1,558,034
TRVI icon
310
Trevi Therapeutics
TRVI
$2B
-50,861
EMPD
311
Empery Digital
EMPD
$151M
-100,000
VMEO
312
DELISTED
Vimeo
VMEO
-135,806
WDC icon
313
Western Digital
WDC
$125B
-32,487
WOLF icon
314
Wolfspeed
WOLF
$1.23B
0
XBI icon
315
State Street SPDR S&P Biotech ETF
XBI
$8.86B
0
BCAX
316
Bicara Therapeutics
BCAX
$1.55B
-100,000
HCWC
317
Healthy Choice Wellness
HCWC
$6.09M
-300,000
VACHW
318
Voyager Acquisition Corp Warrants
VACHW
$1.78M
-1,839,250
CLYM
319
Climb Bio
CLYM
$434M
-547,173
TSSI
320
TSS Inc
TSSI
$404M
-23,267
PONY
321
Pony AI Inc
PONY
$4.89B
-16,520
LPBBW
322
Launch Two Acquisition Corp Warrant
LPBBW
$1.57M
-2,575,000
UFG
323
Uni-Fuels Holdings
UFG
$29.2M
-121,667
MBVIU
324
M3-Brigade Acquisition VI Corp Units
MBVIU
$305M
-116,500
PAII
325
Pyrophyte Acquisition Corp II
PAII
$276M
-72,900